Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 31
Love0

Topical Efinaconazole 10% for Onychomycosis: Pooled Phase 3 Analysis in White, Black, and Asian Participants

By Chuck Lin No Comments
INTRODUCTIONOnychomycosis, a chronic fungal infection of the nail plate or bed, affects up to 14% of individuals in North America and is the most commonly diagnosed nail disorder in the…
Read More
Dec 31
Love0

Characterizing Safety Outcomes of a Dermal Filler: Injection Site and Timing Insights from the Maude Database

By Chuck Lin No Comments
INTRODUCTIONThe number of aesthetic procedures performed has risen sharply in recent years, increasing 14% from 2019 through 2022. This change is primarily due to a 23% increase in non-surgical aesthetic…
Read More
Dec 31
Love0

A Novel Topical Agent for the Management of Hyperpigmentation, Including Melasma and Age Spots

By Chuck Lin No Comments
INTRODUCTIONMelasma is a chronic hyperpigmentation disorder that affects approximately 1% of the general population and up to 1 in 2.5 people in high-risk groups and poses a major therapeutic challenge…
Read More
Dec 29
Love0

Clinical Evaluation of a Thiamidol-Based Regimen With SPF Compared With SPF Alone for Facial Hyperpigmentation

By Chuck Lin No Comments
INTRODUCTIONPigmentary disorders (particularly melasma, postinflammatory hyperpigmentation, and solar lentigines) are among the most common skin disorders, impacting patient quality of life, perception by others, and even self-perception.1,2 Hyperpigmentation results from…
Read More
Dec 29
Love0

Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic Dermatitis in the United States

By Chuck Lin No Comments
INTRODUCTIONAtopic dermatitis (AD) is a chronic, systemic disease that impacts individuals of all ages, races, and ethnicities worldwide. It is strongly influenced by genetic, socioeconomic, and environmental factors and is…
Read More
Dec 27
Love0

From Misdiagnosis to Resistance: The Need for Antifungal Stewardship in Dermatology

By Chuck Lin No Comments
INTRODUCTIONDermatophytoses, fungal infections of the skin, hair, and nails, affect approximately 25% of the global population, and reports of antifungal therapy-resistant infections have risen over the past decade.1 A major…
Read More
Dec 27
Love0

Unveiling Artificial Intelligence’s Diagnostic Power and Challenges in Dermatology for Skin of Color: A Review

By Chuck Lin No Comments
INTRODUCTIONArtificial intelligence (AI) has the ability to revolutionize the diagnostic outcomes and accessibility of dermatology.¹ This study scrutinizes the application of AI in dermatology, specifically assessing its effectiveness in diagnosing…
Read More
Dec 27
Love0

Illuminating LiDAR Use in Dermatologic Surgery: A Pilot Survey Exploring New Dimensions in Procedural Care

By Chuck Lin No Comments
INTRODUCTIONPhotography is essential in dermatology for longitudinal comparisons and referrals. While advancements in cameras and mobile phones/tablets have increased technology accessibility, these modalities are limited to two-dimensional (2D) imaging.1 Current…
Read More
Dec 27
Love0

A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma

By Chuck Lin No Comments
INTRODUCTIONMelasma is a chronic condition characterized by often symmetrical areas of hyperpigmentation affecting the cheeks, nose, chin, and forehead. Genetics, hormonal influences, ultraviolet, and visible light exposure are significant contributing…
Read More
Dec 23
Love0

Updated Insights From an Expanded Survey on Monopolar Radiofrequency Treatment

By Chuck Lin No Comments
INTRODUCTIONThermage® FLX is an advanced, non-invasive monopolar radiofrequency (RF) device used in aesthetic dermatology to address skin laxity and signs of aging. Building on the success of earlier Thermage models,…
Read More
Dec 23
Love0

Combined Use of Relabotulinum Toxin A and NASHA Gel Skinbooster for Rejuvenation of the Upper Third of the Face

By Chuck Lin No Comments
INTRODUCTIONRejuvenation of the upper third of the face is integral to achieving comprehensive facial aesthetic restoration. Prominent age-related changes in this region include dynamic rhytides secondary to repetitive frontalis muscle…
Read More
Dec 22
Love0

Photodistributed Hyperpigmentation Associated With COVID-19 Vaccination

By Chuck Lin No Comments
INTRODUCTIONUp to twenty percent of all cases of acquired hyperpigmentation are postulated to be drug-induced. The incidence and pathogenesis of drug-induced hyperpigmentation are unclear and vary based on the offending…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Efficacy and Safety of Topical Metformin vs Kligman Formula in the Treatment of Melasma: A Split-Face Study May 29, 2026
  • Longer Pembrolizumab Therapy Reduces Mortality in Stage III and IV Melanoma: A TriNetX Study May 28, 2026
  • Clinical Methodology to Evaluate the Efficacy of a Topical Cosmetic Eye Formulation on the Appearance of Dynamic Periorbital Lines May 27, 2026
  • Safety and Efficacy of Aminolevulinic Acid 20% Topical Solution Activated by Blue Light for Facial Cutaneous Squamous Cell Carcinoma in situ May 26, 2026
  • Benzoyl Peroxide and Malignancy Risk: A Systematic Review and Meta-analysis of Over 4 Million Patients May 22, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference LVD        PDE       

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram